Literature DB >> 22836266

Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility.

Claudia R Vianna1, Jose Donato, Jari Rossi, Michael Scott, Kyriakos Economides, Lauren Gautron, Stephanie Pierpont, Carol F Elias, Joel K Elmquist.   

Abstract

The cannabinoid receptor 1 (CB(1)R) is required for body weight homeostasis and normal gastrointestinal motility. However, the specific cell types expressing CB(1)R that regulate these physiological functions are unknown. CB(1)R is widely expressed, including in neurons of the parasympathetic branches of the autonomic nervous system. The vagus nerve has been implicated in the regulation of several aspects of metabolism and energy balance (e.g., food intake and glucose balance), and gastrointestinal functions including motility. To directly test the relevance of CB(1)R in neurons of the vagus nerve on metabolic homeostasis and gastrointestinal motility, we generated and characterized mice lacking CB(1)R in afferent and efferent branches of the vagus nerve (Cnr1(flox/flox); Phox2b-Cre mice). On a chow or on a high-fat diet, Cnr1(flox/flox); Phox2b-Cre mice have similar body weight, food intake, energy expenditure, and glycemia compared with Cnr1(flox/flox) control mice. Also, fasting-induced hyperphagia and after acute or chronic pharmacological treatment with SR141716 [N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole carboxamide] (CB(1)R inverse agonist) paradigms, mutants display normal body weight and food intake. Interestingly, Cnr1(flox/flox); Phox2b-Cre mice have increased gastrointestinal motility compared with controls. These results unveil CB(1)R in the vagus nerve as a key component underlying normal gastrointestinal motility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836266      PMCID: PMC4804760          DOI: 10.1523/JNEUROSCI.4507-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.

Authors:  Marco Landi; Tiziano Croci; Murielle Rinaldi-Carmona; Jean-Pierre Maffrand; Gérard Le Fur; Luciano Manara
Journal:  Eur J Pharmacol       Date:  2002-08-16       Impact factor: 4.432

2.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

Authors:  G Marsicano; B Lutz
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

3.  Companies throw their weight behind new antiobesity drugs.

Authors:  Lauren Cahoon
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

4.  The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.

Authors:  A A Izzo; N Mascolo; L Pinto; R Capasso; F Capasso
Journal:  Eur J Pharmacol       Date:  1999-11-12       Impact factor: 4.432

5.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

Authors:  Nina Balthasar; Roberto Coppari; Julie McMinn; Shun M Liu; Charlotte E Lee; Vinsee Tang; Christopher D Kenny; Robert A McGovern; Streamson C Chua; Joel K Elmquist; Bradford B Lowell
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

7.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.

Authors:  C Ravinet Trillou; C Delgorge; C Menet; M Arnone; P Soubrié
Journal:  Int J Obes Relat Metab Disord       Date:  2004-04

Review 9.  CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health.

Authors:  Daniela Cota
Journal:  Diabetes Metab Res Rev       Date:  2007-10       Impact factor: 4.876

10.  Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

Authors:  Galina Burdyga; Simon Lal; Andrea Varro; Rod Dimaline; David G Thompson; Graham J Dockray
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

View more
  28 in total

Review 1.  The role of gastrointestinal vagal afferent fibres in obesity.

Authors:  Stephen J Kentish; Amanda J Page
Journal:  J Physiol       Date:  2014-12-23       Impact factor: 5.182

2.  Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways.

Authors:  Nicholas V DiPatrizio; Miki Igarashi; Vidya Narayanaswami; Conor Murray; Joseph Gancayco; Amy Russell; Kwang-Mook Jung; Daniele Piomelli
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

3.  Incretin secretion in humans is under the influence of cannabinoid receptors.

Authors:  Chee W Chia; Olga D Carlson; David D Liu; Isabel González-Mariscal; Sara Santa-Cruz Calvo; Josephine M Egan
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

4.  Nutritional status-dependent endocannabinoid signalling regulates the integration of rat visceral information.

Authors:  Abdessattar Khlaifia; Isabelle Matias; Daniela Cota; Fabien Tell
Journal:  J Physiol       Date:  2017-03-27       Impact factor: 5.182

5.  In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.

Authors:  R Abalo; C Chen; G Vera; J Fichna; G A Thakur; A E López-Pérez; A Makriyannis; M I Martín-Fontelles; M Storr
Journal:  Neurogastroenterol Motil       Date:  2015-09-20       Impact factor: 3.598

Review 6.  Intestinal lipid-derived signals that sense dietary fat.

Authors:  Nicholas V DiPatrizio; Daniele Piomelli
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 7.  The Role of the Endocannabinoid System in the Brain-Gut Axis.

Authors:  Keith A Sharkey; John W Wiley
Journal:  Gastroenterology       Date:  2016-04-29       Impact factor: 22.682

8.  PPARγ in vagal neurons regulates high-fat diet induced thermogenesis.

Authors:  Chen Liu; Angie L Bookout; Syann Lee; Kai Sun; Lin Jia; Charlotte Lee; Swalpa Udit; Yingfeng Deng; Philipp E Scherer; David J Mangelsdorf; Laurent Gautron; Joel K Elmquist
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

9.  Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but does not Additively Reduce Body Weight or Eating.

Authors:  Bharath K Mani; Carlos M Castorena; Claudia R Vianna; Charlotte E Lee; Nathan P Metzger; Prasanna Vijayaraghavan; Sherri Osborne-Lawrence; Joel K Elmquist; Jeffrey M Zigman
Journal:  Neuroscience       Date:  2019-09-12       Impact factor: 3.590

Review 10.  The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.

Authors:  C Hasenoehrl; U Taschler; M Storr; R Schicho
Journal:  Neurogastroenterol Motil       Date:  2016-08-26       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.